Exosome-Depleted FBS: Removing Endogenous Vesicle Interference from Extracellular Vesicle Research

Exosome-Depleted FBS: Removing Endogenous Vesicle Interference from Extracellular Vesicle Research

Inconsistent extracellular vesicle (EV) data — inflated nanoparticle tracking analysis (NTA) counts, unexpected bands on Western blots of EV markers, or xenogeneic RNA appearing in sequencing libraries — frequently trace back to a single source: the bovine extracellular vesicles naturally present in standard fetal bovine serum. Exosome-depleted FBS is produced to eliminate this interference while preserving the nutritional performance required for routine cell culture.

1. What Is Exosome-Depleted FBS?

Exosome-depleted FBS is a specialized cell culture serum prepared by multi-stage ultracentrifugation combined with nanofiltration. The process removes more than 95% of endogenous bovine extracellular vesicles while fully retaining the growth factors, amino acids and hormones required for cell proliferation. Conventional FBS naturally contains abundant 30–150 nm bovine vesicles carrying bovine proteins and miRNA, which become mixed into cell culture supernatant and confound downstream EV detection. In qualified exosome-depleted FBS, the CD63 marker level is below 3.125 pg/mL, substantially reducing exogenous background while maintaining both culture stability and experimental purity.

2. Key Differences from Conventional FBS

The basal nutritional composition of the two products is comparable; the differences center on vesicle content and downstream compatibility. Because conventional FBS is not subjected to vesicle depletion, bovine vesicles are co-isolated with cell-derived EVs during supernatant processing. This produces artificially high NTA particle counts, nonspecific bands in Western blot detection of EV markers, and contamination of sequencing libraries with xenogeneic RNA.

Exosome-depleted FBS removes the vesicular fraction while supporting a population doubling time of <18 h and a colony-forming efficiency of >80%. Cell proliferation and attachment are not significantly different from those observed with conventional serum: only the exogenous vesicular background is eliminated, with no compromise to culture performance.

3. When Should Exosome-Depleted FBS Be Used?

• EV isolation and characterization — NTA particle sizing, transmission electron microscopy morphology, and Western blot detection of CD9, CD63 and TSG101.

• EV functional and mechanistic studies — tumor cell vesicle-mediated migration, stem cell paracrine communication, and immune cell extracellular vesicle regulation.

• EV transcriptomic and proteomic sequencing — preventing bovine nucleic acid and protein contamination of sequencing libraries.

• Vesicle marker screening and in vitro disease microenvironment models — where a defined vesicle-free baseline is required.

For routine proliferation and passaging without EV readouts, conventional FBS remains an appropriate and economical choice.

4. Practical Technical Considerations

Repeated freeze–thaw cycles may cause trace protein crystallization; before NTA-based vesicle quantification, a low-speed centrifugation step removes the precipitate without affecting the culture activity of the serum. During culture, replace with exosome-depleted complete medium when cells reach 60%–70% confluence, and limit supernatant collection to a 24–48 h window to reduce background from apoptotic debris. Aseptic technique should be maintained throughout the workflow.

Qualified exosome-depleted FBS passes mycoplasma, adventitious virus and endotoxin testing and is compatible with tumor cells, mesenchymal stem cells, epithelial cells and a broad range of commonly used lines, measurably improving the reproducibility of parallel experiments.

Absin exosome-depleted FBS is purpose-designed for extracellular vesicle research. Collected aseptically from healthy bovine fetuses and processed through multi-stage filtration combined with a specialized membrane filtration step, it removes over 96% of endogenous bovine exosomes (residual CD63 < 3.125 pg/mL) and is mycoplasma-free, endotoxin-controlled and consistent across production lots.

Contact Absin

Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

Absin Bioscience Inc. worldwide@absin.cn

Follow us on Facebook: Absin Bio